Top compounds associated with response to CLYBL


Feature Type Standardized
Nominal ANOVA
mRNA TAE684 GDSC1000 pan-cancer AAC -0.0041 0.9
mRNA niclosamide CTRPv2 pan-cancer AAC -0.0027 0.9
mRNA Tipifarnib GDSC1000 pan-cancer AAC -0.0025 0.9
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.0024 0.9
mRNA GW 441756 GDSC1000 pan-cancer AAC 0.002 1
mRNA GDC-0941 CTRPv2 pan-cancer AAC 0.0019 1
mRNA IPA-3 GDSC1000 pan-cancer AAC 0.0017 1
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0017 1
mRNA masitinib GDSC1000 pan-cancer AAC 0.0015 1
mRNA CHIR-99021 CTRPv2 pan-cancer AAC -0.0016 1
Download CSV